FUREN Group Pharmaceutical Co.,Ltd.

SHSE:600781 Stock Report

Market Cap: CN¥482.9m

FUREN Group PharmaceuticalLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure12.1yrs

Recent management updates

Recent updates


CEO

FUREN Group PharmaceuticalLtd has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Cheng Gong Zhu
Vice Chairman & Board Secretary12.1yrsno datano data
Wen Liang Zhu
Deputy GM & Director14.8yrsno datano data
Wenyu Zhu
Chairman of the Board of Supervisors12.1yrsno datano data
Hui An
Supervisor12.1yrsno datano data
Zhihua Jiang
Chairman3yrsno datano data
Weidong Chen
Independent Director3yrsno datano data
Qinggong Yan
Independent Director3yrsno datano data

12.1yrs

Average Tenure

52yo

Average Age

Experienced Board: 600781's board of directors are seasoned and experienced ( 12.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.